Answers are grounded in this paper and cite their sources.
Age is a risk factor for several psychiatric disorders. An adolescent peak in striatal dopamine availability is thought to contribute to the neuropsychiatric vulnerability. However, the lifespan trajectory of striatal dopamine release capacity is undefined in most species. Here, we measured lifespan trajectories of striatal dopamine in primates and rodents and identified a delayed developmental peak in adulthood and age-dependent changes in dopamine release regulation by GABA and acetylcholine across species.
No takes yet. Share an insight, caveat, or question.
White et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: